Phase Genomics Inc.
Seattle, WA Phase Genomics, Inc.
- UEI
- TQ67ST6YELX5
- CAGE
- 7BWU2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1617 8th Ave N, Seattle, WA 98109, USA
- Website
- phasegenomics.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Harnessing mrna vaccine technology for precision antimicrobial delivery - abstract the rise of antimicrobial… | National Institute of Allergy and Infectious Diseases | $299,163 | |
| Next-generation sequencing of long- and short-read DNA and RNA for draft genome assembly. | National Oceanic and Atmospheric Administration | $19,650 | |
| Proximity ligation library preparation and sequencing | Pacific West Area | $15,900 | |
| ARS-abbl scientists will provide the vendor with nine piglet fecal samples, and the vendor will construct libraries… | Central Program Planning Coordination and Support | $14,220 | |
| Chromosomal aberration detection in ffpe tissue using proximity ligation sequencing - abstract the detection of… | National Cancer Institute | $2,858,324 |
About Phase Genomics Inc.
Phase Genomics Inc. is a biotechnology company based in Seattle, Washington, specializing in advanced genomic sequencing and analysis services. The company focuses on providing sophisticated genomic solutions utilizing proximity ligation techniques, particularly Hi-C technology, which enables high-resolution genome assembly and structural variation analysis. Their services primarily target federal agencies across multiple scientific domains, including agricultural research, marine biology, infectious disease research, and genetic diagnostics.
Through federal contract awards, Phase Genomics has consistently provided specialized genomic sequencing services to various federal agencies. These contracts, predominantly set aside for small businesses, have included next-generation sequencing projects for agencies like the National Oceanic and Atmospheric Administration (NOAA) and the U.S. Department of Agriculture's Agricultural Research Service. Specific contract work has encompassed genome sequencing for marine species like sea scallops and rainbow trout, plant species genomics for fescue and penstemon, and microbiome-related research involving fecal sample analysis. The contract values have ranged from approximately $4,999 to $46,500, demonstrating the company's ability to execute precise, targeted genomic research projects across different biological systems.
Phase Genomics has secured multiple significant federal grants, primarily from institutes like the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Human Genome Research Institute. These grants have focused on cutting-edge research areas such as developing novel antimicrobial approaches using mRNA technology, creating advanced cytogenomic diagnostic methods for cancer research, and developing computational platforms for discovering viral genomes and identifying their hosts. The grant work has emphasized innovative approaches like proximity ligation sequencing, machine learning-based host-range prediction for bacteriophages, and developing diagnostic technologies for chromosomal aberration detection. Grant values have ranged from approximately $14,250 to $299,163, reflecting the company's capability to conduct sophisticated, forward-looking research with potential significant medical and scientific implications.
Quick answers
What is Phase Genomics Inc.'s UEI?
Phase Genomics Inc.'s Unique Entity ID (UEI) in SAM.gov is TQ67ST6YELX5.
What is Phase Genomics Inc.'s CAGE code?
Phase Genomics Inc.'s CAGE code is 7BWU2.
What is Phase Genomics Inc.'s primary NAICS code?
Phase Genomics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Phase Genomics Inc. located?
Phase Genomics Inc.'s physical address in SAM.gov is 1617 8th Ave N, Seattle, WA 98109, USA.
Is Phase Genomics Inc. registered in SAM.gov?
Yes. Phase Genomics Inc.'s SAM.gov registration is active through October 29, 2026.
What is Phase Genomics Inc.'s most recent federal award?
Phase Genomics Inc.'s most recent federal grant award is Harnessing mrna vaccine technology for precision antimicrobial delivery - abstract the rise of antimicrobial… (R43AI192163), from National Institute of Allergy and Infectious Diseases, on April 22, 2025.
On GovTribe
See Phase Genomics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors